On ECHEMI
Home > Drugs > Acute pancreatitis
Acute pancreatitis
Acute pancreatitis (AP) is a relatively common acute abdomen, and its incidence ranks third to fifth among acute abdomens. More than 80% of patients have mild symptoms, namely acute edematous pancreatitis, which can be cured by non-surgical means and is basically a medical disease. About 10% of patients have severe pancreatitis, namely acute hemorrhagic necrotizing pancreatitis. The inflammation of the pancreas is no longer reversible or self-limiting, and often requires surgical treatment. It should be regarded as a surgical disease. Due to the in-depth understanding of acute pancreatitis, the diagnostic technology and treatment methods have been greatly developed, and it has become a very interesting issue for surgeons. At the same time, the mortality rate remains high, reaching 30% to 60%, and various serious complications are prone to occur, which is a severe challenge for doctors.
  • Site of disease:

    pancreas
  • Infectious :

    Not contagious
  • Frequent population:

    All people, any occurrence during pregnancy...
  • Related symptoms:

    Pancreatic abdominal pain Sudden right upper abdominal colic Nausea and vomiting Acute abdomen Upper abdominal tenderness
Related Drugs
Octreotide Acetate Injection
Indication: Digestive system medications. Esophageal gastric venous bleeding, peptic ulcer and emergency ulcer, acute pancreatitis, prevention of complications after pancreatic surgery, gastrointestinal pancreatic endocrine tumors, acromegaly.
Octreotide Acetate Injection
Indication: Digestive system medications. Esophageal gastric venous bleeding, peptic ulcer and emergency ulcer, acute pancreatitis, prevention of complications after pancreatic surgery, gastrointestinal pancreatic endocrine tumors, acromegaly.
Octreotide Acetate Injection
Indication: Digestive system medications. Esophageal gastric venous bleeding, peptic ulcer and emergency ulcer, acute pancreatitis, prevention of complications after pancreatic surgery, gastrointestinal pancreatic endocrine tumors, acromegaly.
Octreotide Acetate Injection
Indication: Digestive system medications. Esophageal gastric venous bleeding, peptic ulcer and emergency ulcer, acute pancreatitis, prevention of complications after pancreatic surgery, gastrointestinal pancreatic endocrine tumors, acromegaly.
Manufacturer:

Chengdu Tiantai Mountain Pharmaceutical Co., Ltd.

  • 1
  • 2
  • Go to Page Go
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.